Radio and PodcastRadio and PodcastLive Radio & Podcasts
Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy artwork
Religion & Spirituality

Heart Failure with Preserved Ejection Fraction (Diastolic CHF) and SGLT-2 Inhibitor Therapy

Hospital and Internal Medicine Podcast by Gil Porat, M.D., FACP, CPT

Jan 27, 202211:32Religion & Spirituality

The double-blind, randomized phase III EMPEROR-Preserved trial showed a benefit of the sodium-glucose cotransporter-2 (SGLT2) inhibitor empagliflozin in patients with heart failure with preserved ejection fraction (HFpEF...